RxDoctor Payments Data

Jacob Bolz

Physician Assistant · Lakeside, CANPI 1386025682

Payments from drug & device makers

$2,876in general payments, 2019–2025

Across 132 payments — averaging $21.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$824
  • Lilly USA, LLC$522
  • AstraZeneca$236
  • GSK$219
  • Boehringer Ingelheim$172
  • Novo Nordisk$168
  • plus $735 from 18 others

What the payments were for

  • Food & beverage$2,876100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,876 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide63$60,535
MounjaroTirzepatide32$37,950
JardianceEmpagliflozin31$34,099
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,041
UbrelvyUbrogepant14$13,998
TrulicityDulaglutide14$13,763
MyrbetriqMirabegron14$8,234
KerendiaFinerenone13$7,806
Trijardy XrEmpaglifloz/Linaglip/Metformin13$7,238
LinzessLinaclotide12$6,447
BrilintaTicagrelor12$4,951
Gabapentin34$767
Atorvastatin Calcium65$664
Losartan Potassium55$579
Baclofen30$417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$168$60,53563 claims
Lilly USA, LLCMounjaro, Trulicity$522$51,71346 claims
Boehringer IngelheimJardiance, Trijardy Xr$172$41,33744 claims
AbbVieUbrelvy, Linzess$824$20,44526 claims
GSKTrelegy Ellipta$219$16,04121 claims
Astellas Pharma US IncMyrbetriq$20$8,23414 claims
BayerKerendia$71$7,80613 claims
AstraZenecaBrilinta$236$4,95112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Lakeside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →